Ritonavir film coated is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Cipla Usa Inc.. The primary component is Ritonavir.
Product ID | 69097-655_127233bc-ed5c-470a-bc45-3313b08346b7 |
NDC | 69097-655 |
Product Type | Human Prescription Drug |
Proprietary Name | Ritonavir film coated |
Generic Name | Ritonavir 100 Mg |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2022-03-23 |
Marketing Category | ANDA / |
Application Number | ANDA202573 |
Labeler Name | Cipla USA Inc. |
Substance Name | RITONAVIR |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inducers [MoA], Cytochrome P450 3A Inhibitor [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], HIV Protease Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], Protease Inhibitor [EPC], UDP Glucuronosyltransferases Inducers [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-04-25 |
NDC Exclude Flag | N |
Sample Package? | N |